J9028 HCPCS Level II code: Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
J9028 is the HCPCS code for “Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Short description: Inj, nogapendekin pmln, 1mcg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9028 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2025
Where J9028 sits
- 1J codesDrugs administered other than orally
- 2Active code J9028Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9028 mean?
J9028 is the HCPCS code for “Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9028?
CMS lists J9028’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9028
All J codesJ9022Injection, atezolizumab, 10 mgJ9023Injection, avelumab, 10 mgJ9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjsJ9025Injection, azacitidine, 1 mgJ9026Injection, tarlatamab-dlle, 1 mgJ9027Injection, clofarabine, 1 mgJ9029Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic doseJ9030Bcg live intravesical instillation, 1 mgJ9031Bcg (intravesical) per instillationJ9032Injection, belinostat, 10 mgJ9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mgJ9034Injection, bendamustine hcl (bendeka), 1 mg